Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.042,61
1,15%
NASDAQ
20.022,25
-0,04%
Bitcoin
95.593,04
-3,73%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cartesian Therapeutics Inc (RNAC) Cartesian Therapeutics Inc (RNAC) Notizie

Cartesian Therapeutics Inc

RNAC
19,595
1,13 (6,09%)
Ultimo aggiornamento: 18:57:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
18/12/202413:05GLOBECartesian Therapeutics Announces New Employment Inducement..
13/12/202422:16EDGAR2Form S-3 - Registration statement under Securities Act of..
13/12/202422:11EDGAR2Form S-3 - Registration statement under Securities Act of..
13/12/202422:06EDGAR2Form S-3 - Registration statement under Securities Act of..
11/12/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/12/202422:21EDGAR2Form 144 - Report of proposed sale of securities
09/12/202422:36EDGAR2Form 144 - Report of proposed sale of securities
03/12/202412:03EDGAR2Form 8-K - Current report
03/12/202412:00GLOBECartesian Therapeutics Announces Positive Updated Results..
22/11/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202400:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202400:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202422:45EDGAR2Form 144 - Report of proposed sale of securities
21/11/202413:00GLOBECartesian Therapeutics to Present Updated Data from Phase 2b..
20/11/202422:57EDGAR2Form 144 - Report of proposed sale of securities
19/11/202422:36EDGAR2Form 144 - Report of proposed sale of securities
19/11/202401:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202401:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/11/202401:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202422:24EDGAR2Form 144 - Report of proposed sale of securities
15/11/202423:07EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:57EDGAR2Form 144 - Report of proposed sale of securities
15/11/202422:44EDGAR2Form 144 - Report of proposed sale of securities
14/11/202423:30EDGAR2Form 144 - Report of proposed sale of securities
14/11/202423:29EDGAR2Form 144 - Report of proposed sale of securities
14/11/202423:13EDGAR2Form 144 - Report of proposed sale of securities
08/11/202413:05GLOBECartesian Therapeutics Announces New Employment Inducement..
07/11/202413:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/11/202413:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202413:06EDGAR2Form 8-K - Current report
07/11/202413:00GLOBECartesian Therapeutics Reports Third Quarter 2024 Financial..
05/11/202415:00GLOBECartesian Therapeutics Announces Presentation at the..
15/10/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/10/202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/10/202422:30EDGAR2Form SC 13D/A - General Statement of Acquisition of..
15/10/202413:00GLOBECartesian Therapeutics Announces Presentation of Results..
04/10/202413:05GLOBECartesian Therapeutics Announces New Employment Inducement..
01/10/202422:36EDGAR2Form 424B7 - Prospectus [Rule 424(b)(7)]
26/9/202413:02EDGAR2Form 8-K - Current report
09/9/202413:00GLOBECartesian Therapeutics Receives FDA Rare Pediatric Disease..
06/9/202413:05GLOBECartesian Therapeutics Announces New Employment Inducement..
03/9/202413:00GLOBECartesian Therapeutics Announces First Patient Dosed in..
26/8/202413:00GLOBECartesian Therapeutics to Participate in Upcoming Investor..
08/8/202413:00GLOBECartesian Therapeutics Reports Second Quarter 2024 Financial..
07/8/202422:05GLOBECartesian Therapeutics Announces New Employment Inducement..
08/7/202422:05GLOBECartesian Therapeutics Announces New Employment Inducement..
02/7/202422:05GLOBECartesian Therapeutics Strengthens Board of Directors with..
02/7/202412:31GLOBECartesian Therapeutics Announces $130 Million Private..
02/7/202412:30GLOBECartesian Therapeutics Announces Positive Topline Results..
06/6/202413:05GLOBECartesian Therapeutics Announces New Employment Inducement..
Apertura: 18,27 Min: 18,27 Max: 19,8493
Chiusura: 18,47

La tua Cronologia

NASDAQ
RNAC
Cartesian Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network